Funding for this research was provided by:
National Institute on Aging (R01 AG055526)
Biomedical Laboratory Research and Development, VA Office of Research and Development (BX004105)
Text and Data Mining valid from 2019-12-01
Received: 6 November 2019
Accepted: 3 December 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: The study has been approved by the Stanford University Human Subjects in Medical Research Institutional Review Board (IRB Administrative Panel 3), Palo Alto, CA 94306 (#FWA00000935) and the National Institutes of Health (NIH) Human Subjects Program in the Office of Extramural Programs. Written informed consent is obtained from study participants at the initial, in-person screening visit (t<sub>1</sub>) by the Study Coordinator and/or Protocol Director. All of the procedures involved, their risks, the potential benefits, and issues of confidentiality, provisions for collection and use of participant data and biological specimens, and provisions for care in the event of harm from trial participation are addressed in the informed consent documents (Additional file InternalRef removed).Enough time is allowed for the potential participant to make an informed decision, including time to ask the researchers any questions they may have and discuss the study with others. If the prospective participant lacks adequate decision-making capacity, a designated legal representative will need to sign the consent form, and the participant will need to co-sign to indicate assent. The Research Compliance Officer of the VA Palo Alto Health Care System independently conducts annual audits of the participants’ informed consent documents.
: Not applicable.
: The authors declare that they have no competing interests.